Washington, D.C. – Nearly 70% of middle and high school students who currently use tobacco report the use of flavored products, according to data released by the Centers for Disease Control and Prevention (CDC) today.
Washington, D.C. – Today the Senate Health, Education, Labor and Pension (HELP) Committee will meet to vote on the nomination of Dr. Stephen Hahn as the next commissioner of the Food and Drug Administration (FDA). Approval of Dr.
WASHINGTON, D.C. – Our organizations have commended President Trump and his Administration for recognizing the severity of the youth e-cigarette epidemic and the need for bold action to prevent e-cigarettes from addicting a generation of children.
Washington, D.C. – The following is a statement from American Cancer Society Cancer Action Network President Lisa Lacasse, responding to media reports that the U.S.
Washington, D.C. – Today the House Energy and Commerce Committee held a markup on legislation that would prohibit the sale of nearly all flavored tobacco products, including mint and menthol products, and raise the minimum age of sale of tobacco products to 21.
ACS CAN joings public health groups expressing alarm about reports that the Trump Administration may be backing away from its plan to clear the market of all flavored e-cigarettes and may be considering allowing the continued sale of flavored e-cigarettes in vape shops.
The White House announced today it will nominate Dr. Stephen Hahn, an oncologist and chief medical executive at MD Anderson Cancer Center in Houston, as commissioner of the Food and Drug Administration (FDA).
Today the U.S. Senate will vote on a resolution under the Congressional Review Act that would stop Department of Health and Human Services (HHS) and Department of the Treasury guidance allowing individuals to use federal tax subsidies to purchase health insurance that does not meet coverage standards under the Affordable Care Act (ACA).
Washington, D.C. – Barriers to accessing appropriate therapies to address the physical and psychological side effects of cancer treatment continue to persist for patients and survivors, according to survey results from the American Cancer Society Cancer Action Network (ACS CAN).